We continue to believe our shares are attractively priced at current levels and therefore, we currently intend to repurchase all of the shares issued within the next two years-- and that's in addition to what we planned to repurchase in the absence of the transaction.
"We worked very hard to identify a group of patients who had reached the limits of conventional treatment - for whom there is currently no effective therapy and therefore are at the greatest risk of death from the condition, " Dr Lipsman said.